Monitor for follow-on activity from active managers or insiders — if active funds begin accumulating, it could confirm a broader shift in sentiment. Also watch for any upcoming clinical trial readouts or regulatory catalysts that may have prompted the passive index inflows.
Executive Summary
Three major passive institutional investors — Morgan Stanley, Wells Fargo, and UBS — significantly increased their positions in LENZ Therapeutics during Q4 2024, with UBS doubling its stake and driving the largest dollar addition. The coordinated buying across institutions signals growing institutional interest in this small-cap biotech, though all buyers are passive managers, suggesting the moves may reflect index rebalancing rather than active conviction.
Key Financial Metrics
Institutional Positions
Net institutional flow: $3.9M
▲ Buyers (3)
| Institution | Action | Change | Position Value | Value Δ |
|---|---|---|---|---|
| Morgan Stanley | ADD | +82.8% | $2.7M | $1.5M |
| Wells Fargo | ADD | +27.3% | $217.0K | $77.0K |
| UBS | DOUBLED | +1298.3% | $2.5M | $2.3M |
Key Facts
- Morgan Stanley increased holdings by 82.8%, adding 41.8K shares (value up $1.5M to $2.7M)
- Wells Fargo added 1.6K shares (+27.3%), increasing exposure from $140K to $217K
- UBS DOUBLED its position, surging 1298.3% from 6.1K to 85.9K shares, with value jumping from $146K to $2.5M (+$2.3M)
- No institutional selling observed in the quarter; net buying totaled $3.9M across three passive giants
Financial Impact
3 institutions accumulated $3.9M in net new positions during Q4 2024, bringing total institutional holdings in LENZ to $5.4M
Risk Factors
- All buyers are passive/mega-passive institutions, indicating the buying may be due to index inclusion or rebalancing rather than fundamental conviction
- Small absolute position sizes suggest limited conviction; total holdings remain under $6M despite coordinated moves
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 institutional 13F filing from SEC EDGAR.
| Document | Accession Number |
|---|---|
| INST-CLUSTER Data (Synthetic) | inst-cluster-LENZ-2024-Q4 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 22, 2026 5d ago | Press Release | $3.25 | awaiting T+1 | — | — |
Oct 21, 2026 5d ago | SC 13G/A | $3.25 $3.16 | ▼ −2.77% | ▼ −2.25% | — |
Aug 11, 2026 11w ago | Press Release | $5.04 $4.60 | ▼ −8.73% | ▼ −9.43% | — |
Jul 2, 2026 16w ago | 8-K | $5.89 $5.60 | ▼ −4.92% | ▼ −5.80% | — |
Jun 11, 2026 19w ago | Institutional Cluster | $6.50 $6.77 | ▲ +4.15% | ▲ +3.61% | — |
Jun 7, 2026 20w ago | Press Release | $6.72 $6.79 | ▲ +1.04% | ▲ +1.34% | — |
May 11, 2026 24w ago | 8-K | $7.91 $7.91 | · 0.00% | ▼ −0.54% | — |
May 4, 2026 25w ago | Press Release | $9.28 $9.07 | ▼ −2.26% | ▼ −3.06% | — |
Mar 24, 2026 31w ago | Press Release | $9.03 $9.07 | ▲ +0.44% | ▼ −0.12% | — |
Feb 28, 2026 34w ago | Institutional Cluster | $13.68 $13.15 | ▼ −3.87% | ▼ −2.96% | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers